Achi news desk-
symbolic image
– Photo: ANI
expansion
To curb sale of counterfeit, spurious and substandard pharmaceutical products in the country, the Central Drugs Standard Control Organization (CDSCO) has released draft guidelines on good distribution practices. The guidelines issued by CDSCO are inspired by the World Health Organization’s Technical Reports (TIA) series, which are based on good storage and distribution practices.
It is necessary to prevent defective products from entering the market
According to media reports, the new guidelines will apply to all those people and companies engaged in the storage and distribution of related goods, including medicines. The draft guidelines state that substandard and fake products pose a threat to public health and safety. It is necessary to stop such products from reaching the market. Guidelines: Responsibility will be determined at various stages of the supply chain to prevent substandard products from entering the market. The draft recommends including an inspection by a dedicated and competent person to maintain quality. The process of appointing the person should be independent and detailed.
Appointment of a responsible party, responsibility for quality assurance
The draft states that distributors of pharmaceutical products will have to maintain quality. A responsible person will be appointed by the management of each distribution point. That person will have the responsibility to ensure quality. Also, returned products must be destroyed in accordance with international, national and local requirements while taking into account the protection of the environment.
